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Abstract: 
The preliminary phytochemical analysis  of Eryngium creticum showed that it contained  alkaloids, tannins, resins, 
saponins, coumarin,  phenols, terpenoids, flavonoids and carbohydrates. The previous pharmacological studies 
revealed that Eryngium creticum possessed  antioxidant, antimicrobial, anti-inflammatory, antinociceptive,  
anticancer, antileishmanial  and many other effects. The current review highlights the chemical constituents, 
pharmacological and therapeutic effects of Eryngium creticum. 
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INTRODUCTION: 
In the last few decades there has been an exponential 
growth in the field of herbal medicine. It is getting 
popularized in developing and developed countries 
owing to its natural origin and lesser side effects. Plants 
are a valuable source of a wide range of secondary 
metabolites, which are used as pharmaceuticals, 
agrochemicals, flavours, fragrances, colours, 
biopesticides and food additives [1-16]. The preliminary 
phytochemical analysis  of Eryngium creticum showed 
that it contained  alkaloids, tannins, resins, saponins, 
coumarin,  phenols, terpenoids, flavonoids and 
carbohydrates. The previous pharmacological studies 
revealed that Eryngium creticum possessed antioxidant, 
antimicrobial, anti-inflammatory, antinociceptive,  
anticancer, anti-leishmanial  and many other effects. 
The current review will discuss the chemical 
constituents, pharmacological and therapeutic effects of 
Eryngium creticum. 
 
Synonyms: 
Eryngium cyaneum Sm. and Eryngium syriacum Lam 
[17]. 
 
Taxonomic classification: 
Kingdom: Plantae, Subkingdom: Tracheobionta, 
Superdivision:  Spermatophyta, Division: 
Magnoliophyta, Class: Magnoliopsida, Subclass: 
Rosidae, Order: Apiales, Family: Apiaceae ⁄ 
Umbelliferae, Genus: Eryngium, Species: Eryngium 
creticum [18]. 
Common names: 
Arabic: Shuk Al-Akrabati, Qurs’anna, Qursanna 
ekritiah, English: Eryngo,  Snake root, Field Eryngo 
small-headed, Blue eryngo, Cretan eryngo; French: 
Panicaut de Crete; Italian: Calcatreppola di Creta [19].  
 
Distribution:  
Eryngium creticum is distributed in North Africa 
(Egypt), Asia (Iraq, Palestine, Lebanon,  Syria, Jordan 
and  Turkey) and Europe (Albania,  Bulgaria,  Greece, 
Macedonia, Montenegro and  Slovenia) [20].  
 
Description: 
Eryngium creticum is a spiny perennial, or sometimes 
biennial or annual, glaucous and globrous herb, 
reaching up to 50 cm in height and it has erect branched 
stems. Stem leaves are sessile and palmately divided 
into 3–8 prickly lobes. Winter rosette leaves are quickly 
withering, bluish, long petioled, not prickly, entire to 
dentate, or lobed. Inflorescences are repeatedly forked; 
umbels of 0.7–1 cm, head-like, with an involucre of 5 
long, blue, spiny bracts 2–5 times as long as the head, 
spreading, linear, boat-shaped, prickly at base or along  
 
 
the long margin. Fruits are scaly-bristly, obscurely 
ribbed [21]. 
 
Traditional uses: 
It was cultivated for the consumption as a leafy 
vegetable in salads. It  was used medicinally  as a 
diuretic and  laxative. Roots and seeds were immersed 
in water are drunk by people to treat kidney stones, 
infections, skin diseases, and tumors  as antidote  for the 
treatment of the snakebite. It was also  used for the 
treatment of liver diseases, poisoning, anemia and 
infertility [22-23]. 
 
Chemical constituents: 
The preliminary phytochemical analysis showed that 
the plant contained  alkaloids, tannins, resins, saponins, 
coumarin,  phenols, terpenoids, flavonoids and 
carbohydrates [24-25].  
The total alkaloids in the plant reached  0.57 ± 0.0058 
wt %, humidity 79.16 ± 0.0078 wt %, total ash 18.10 ± 
0.0015 wt %, total phenolic contents 8.57 ±0.006 - 
17.68± 0.0043 µg/ml and   total flavonoids contents  
17.73± 0.012 - 20.19± 0.041 µg/ml [26].   
The highest flavonoids contents was recorded in the 
ethanolic extract of leaves and stems, while the highest  
total phenolic content was recorded in the aqueous 
extract of both leaves and stems [24]. 
The essential oils yield of Eryngium creticum was  
0.21% (v/w). The oils were colorless, with a weak 
perfumery odor. They contained Pentanal  0.97±3.18%, 
-Methylhexane 0.89±2.08 %, Pentan-1-ol 0.54±5.20%, 
3,7-Dimethyloct-1-ene 0.51±3.9%, 2,4-Dimethylhexane 
0.14±1.18%, 3-Ethylhexane 0.43±0.66%, 3,4-
Dimethylhex-1-ene 2.90±2.84%, Octane 8.95±2.32%, 
Hexanal 52.90±2.70%,  6-Methylhepta-3,5-dien-2-one 
2.13±2.74 %, (E)-Hex-2-enal 1.02±3.20%, Acetic acid 
3.57±2.36%,  Heptan-3-one 1.78±3.24%, Non-1-ene 
0.27±2.72%, Heptan-2-one 2.01±3.42%, 2-Butylfuran 
2.79±3.16%, 5-Methylhexan-2-one 0.50±3.44%, 
Nonane 0.56±2.7%, Heptanal 13.90±3.82%, CO2  
0.09±1.94%, Pentanoic acid 0.90±3.10% and  (1R)-a-
Pinene 2.51±3.58% [27]. 
The chemical analysis of  volatile oil of the  stems of 
Eryngium creticum  growing wild  in Iran, showed  that 
the total oil contents was  0.18 w/w %   with  a clear 
yellowish colour.  Seventeen components were 
identified constituting  91.4 % of the oil composition. 
The major components of the oil were found to be 
bornyl acetate (28.4 %), camphor (17.8 %), α-pinene 
(12.1 %), germacrene D (9.4 %), borneol (8.6 %) and α-
thujene (4.2 %). Based upon the chemical profile, the 
essential oil was characterized by the presence of higher 
amounts of oxygenated monoterpenes [28]. 
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Nine fatty acid derivatives were extracted from 
Eryngium creticum: Methyl tetradecanoate  32.56%, 
Methyl hexadecanoate 49.34 %, Methyl 9,12-
octadecanoate 8.59 %, Methyl octadecanoate 13.89 %, 
Cyclohexyl nonyl oxalate 28.94 %, 1-Methylhexyl 
hexanoate 10.89 %, Allyl nonyl oxalate 4.23 %, 2-
propyl tridecylsulphinate 2.93 % and Methyl 4- 
hydroxyl octadecanoate 5.84 % [26]. 
A sesquiterpene, 1-n-propyl-perhydronaphthaline 
1,2,4a,5,6,7,8,8a-octahydro-4-methyl-1-propyl-
naphthalene-7-carbaldehyde and  a new natural methyl 
ketone eicos-8,11 -dien-18-ol-2-one were isolated from  
the hexane: ether extract of the aerial parts of  Eryngium 
creticum
 
[29].  
Phytochemical investigations of the roots of Jordanian  
Eryngium creticum,  showed the presence of  nine 
compounds: two coumarins,  deltion and marmesin, 
cyclic alcohol, quercitol, monoterpeneglycoside 3-( β-
D-glucopyranosyloxymethyl)-2,4,4-trimethyl-2,5-
cyclohexadien-1-one, phloroglucinol glycoside (1-(β-D-
glu-copyranosyloxy-3-methoxy-5-hydroxy benzene)), 
β-sitosteroland and its glycoside (β-sitosterol-β-D-
glucopyranose), and two sugars, mannitol and dulcitol 
[30]. 
 
Pharmacological effects: 
Antidiabetic effect: 
The hypoglycemic activity of an aquous decoction of  
arial parts of Eryngium creticum was tested in 
normoglycemic and streptozocin-hyperglycemic rats. 
Results indicate that those extract caused significant 
reductions in blood glucose concentrationin in 
normoglycemic rats (20%), and streptozocin-
hyperglycemic rats (64.2%)  when given orally [31]. 
The hypoglycemic effects of the aqueous extracts of  
Eryngium creticum aerial parts were  examined in 
normal, glucose loaded and alloxan diabetic 
experimental animals. Eryngium creticum exhibited a 
potent and significant hypoglycemic effects in normal-
fed,  glucose loaded and and alloxan diabetic animals 
[32-34].  
The pancreatic and extrapancreatic effects of of  
Eryngium creticum was studied  using bioassays of β-
cell proliferation and insulin secretion as well as 
glucose diffusion as possible modes of actions.   Similar 
to L-alanine insulinotropic efficacy in MIN6 β-cell, 
glucose-stimulated Ca
2+
 regulated- insulin secretion was 
potentiated by crude aqueous extracts of Eryngium 
creticum (0.01 mg/ml).  Comparable to glucagon-like 
peptide-1-enhanced β-cell proliferation in 2-day 
treatment wells, a dose dependent augmentation of 
bromodeoxyuridine incorporation was obtained with the 
Eryngium creticum crude aqueous extracts (0.1, 0.5 and 
1 mg/ml) [35].  
 
Anti-scorpion  and snake and  venoms: 
Aqueous and ethanol extracts of the fresh and dried 
leaves and roots of Eryngium creticum were tested for 
their inhibitory effect against  snake and scorpion 
venoms. The fresh leaf extract gave a higher 
percentage inhibition of the haemolytic activity of 
the scorpion venom Leiurus quinquesteiartus 
compared with the dried leaf extract. Extracts of 
both fresh and dried roots gave 100% inhibition of 
the snake and scorpion venoms. However, ethanol 
extracts of the leaves and roots enhanced RBC 
haemolysis rather than inhibiting venom activities 
on red blood cells [36].  
Aqueous extract  of  Eryngium creticum in 
combination with  Cerastes snake venom prolonged  the 
life span from 12 to 72 h [37].  
The aqueous extract of Eryngium creticum caused a 
dose  dependent  inhibition of rabbits tracheal and 
jejunal contraction induced by the L. quinquestriatus 
scorpion venom and inhibited the spontaneous 
movements of the jejunum [30, 38]. 
 
Antioxidant effect: 
In estimation of antioxidant activity of Eryngium 
creticum, it appeared that the antioxidant activity of the 
aqueous  extracts of the leaves and stems of Eryngium 
creticum was increased with increasing the 
concentration of the aqueous extract. This increase  was 
reached 59 % and 35 % at the concentration of 0.5 
mg/ml for the leaves and stems respectively. Studies on 
the same plant but from an altitude 300 m showed that 
the leaves and stems at the same concentration (0.5 
mg/ml), exerted an antioxidant activity of 90 % and 75 
% respectively. On the other hand, at a concentration of 
0.5 mg/ml, the ethanolic extract showed an important 
antioxidant activity of both leaves (81 %) and stems (79 
%). However, this antioxidant capacity was highest for 
the plant that grows at 300 m, it  reached the 93 % for 
the leaves and 82 % for the stems. In addition, 
methanolic extract  showed that both leaves and stems 
have exerted an important antioxidant activity reaching 
90 % and 79 % respectively at a concentration of 0.5 
mg/ml [24]. 
Antioxidant power of the Lebanese  Eryngium creticum 
was determined by DPPH assay  using different 
extraction techniques. The results indicated that the 
antioxidant effect was increased with the  concentration, 
the  highest antioxidant activity in all the extraction 
techniques was obtained at a concentration of 0.5 mg/ 
ml [26, 39].   
The  in vitro antioxidant activity  of the aqueous and 
ethanolic extracts from different parts (leaves, stems, 
roots, and the whole plant) of the fresh plant Eryngium 
creticum from the first and second harvest, were  
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performed using antioxidant  DPPH radical scavenging  
and  superoxide radical scavenging tests. The results 
showed that the 4 parts of the plant exerted antioxidant 
activity that may be due to their phenolic content. The 
antioxidant activity of the aqueous extract of leaves, 
stems and roots of Eryngium creticum was increased 
with increasing concentrations. It reached 77% , 89% 
and 70% at the concentration of 0.5 mg/ml of leaves, 
stems and roots, respectively, for the first harvest, 
while, it reached 73%, 59% and 34% at the same 
concentration of the leaves, stems and roots respectively 
for the second harvest. The aqueous extract of the 
whole plant showed an antioxidant activity of 72% at 
the same concentration for the first harvest and 49% for 
the second. The ethanolic extract showed an antioxidant 
activity of 93%, 82% and 44% for leaves, stems and 
roots, respectively, at a concentration of 0.5 mg/ml for 
the first harvest, whilst for the second harvest, the 
antioxidant activity  was  56%, 65% and 61% at the 
same concentration for the leaves, stems and roots, 
respectively [40]. 
The antioxidant effect of  three extracts (aqueous, 
methanolic and ethyl acetate) from fresh leaves and 
stems of Eryngium creticum was studied. The results 
showed that both leaves and stems extracts of the plant 
exerted an antioxidant activity  correlated  to their 
phenolic content [41]. The consumption of 100 g of 
fresh Eryngium creticum leaves and stems provided 
antioxidants activity  equivalent to (78.50±0.80) and 
(50.42±0.50) mg of vitamin C, respectively [25]. 
 
Antimicrobial effect: 
The antibacterial activity of  the Aqueous and ethanolic 
extracts of Eryngium creticum leaves and stems  was 
studied against three Gram positive bacteria 
(Staphylococcus epidermidis CIP 444, Staphylococcus 
aureus ATCC 25923, and Enterococcus faecalis ATCC 
29212) and two Gram negative strains (Escherichia coli 
ATCC 35218 and Pseudomonas aeruginosa ATCC 
27853). Aqueous extracts from Eryngium creticum 
showed stronger antibacterial  activity than the 
ethanolic extracts against both Gram positive and Gram 
negative strains. Among these strains, Gram positive 
ones were more sensitive, with Staphylococcus 
epidermidis being the most inhibited with 
MIC=MBC=5 mg/ml for the leaves aqueous extract, in 
particular in the first harvest period. During the second 
period, however, the activity decreases, to show equal 
concentrations  (MIC = MBC = 27.9  mg/ml). Whereas 
the stem aqueous extract, during the first harvest period, 
exhibited a considerable activity with MIC=26 mg/ml 
and MBC=53 mg/ml [42].  
The antibacterial activity of Eryngium creticum was 
tested against Staphylococcus aureus, Escherichia coli, 
Klebsiella pneumoniae, Proteus vulgaris and 
Pseudomonas aeruginosa using  disc diffusion method. 
The aqueous was  more effective against K. pneumoniae 
than the ethanolic extract, while the ethanolic extract 
was  more effective against P. vulgaris. However, 
against S. aureus, E. coli and P. aeruginosa, there were 
no differences between the effect of the aqueous and 
ethanolic extracts
 
[43].  
The essential oils of  Eryngium creticum were  tested 
for their inhibitory activity  against  nine different 
methicillin-resistant Staphylococcus aureus (MRSA) 
strains by  agar disc diffusion method. Three strains 
showed zone of inhibition 9-11mm, four strains 5-7mm 
and 2 strains resisted  Eryngium creticum essential oils 
[27].  
The antifungal  effect  Eryngium creticum aqueous 
extracts (15 micrograms/ml medium)  was investigated 
against M. canis, T. mentagrophytes and  T. violaceum.  
The percentage of  mycelial inhibition was 12.4±4.26,  
56.6±7.41 and  38.8±7.98% for the three fungi, 
respectively [44].   
 
Anti-inflammatory and antinociceptive effects: 
Ethanolic and aqueous extracts obtained from either 
aerial parts or roots of eight  Eryngium species growing 
in Turkey, were evaluated for their in vivo anti-
inflammatory and antinociceptive  activities, using p-
benzoquinone-induced writhing test   for estimation of  
antinociceptive activity, and carrageenan-induced hind 
paw oedema and TPA-induced ear oedema tests  for  
anti-inflammatory activity. Ethanolic extracts either 
from the aerial parts or roots  of  Eryngium creticum 
showed apparent anti-inflammatory and antinociceptive 
activity [45].  
The anti-inflammatory activity of  extracts prepared 
using different solvents from leaves and stems of 
Eryngium creticum was evaluated by measuring the 
viability of the RAW264.7 macrophage  cell line after 
24 hours treatment with increasing concentrations (5, 
25, 50, 100, and 200 μg/ml) of these extracts. The cell 
viability (XTT test) showed that aqueous extracts of the 
leaves and stems of Eryngium creticum increased the 
number of macrophages (RAW 264.7) with increasing 
concentrations of the extract from 5 to 200 μg/ml 
compared to control [24]. 
 
Anticancer effect: 
Ethanolic extracts of Eryngium creticum were  tested 
against N-methyl-N-nitro-N-nitrosoguanidine (MNNG), 
a directly acting mutagen. Primary cultures of rat 
hepatocytes were used and the plant ethanolic extracts 
were applied along with MNNG in three protocols: pre-
treatment, combined treatment and post-treatment. The 
results indicated an inhibitory effect of the plant 
extracts on MNNG mutagenicity, while the extracts had 
no effect on cytotoxicity indicators such as necrosis and 
apoptosis [46].  
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The cytotoxic effects  of  three extracts (aqueous, 
methanolic and ethyl acetate) from fresh leaves and 
stems of Eryngium creticum, were studied   on MCF7 
breast cancer cell line using  XTT cell viability 
technique.  The results showed that the aqueous and 
ethyl acetate extracts of both leaves and stems of the 
plant inhibited the growth of cancer cell line from 68 % 
to 72 % [41].  
The anticancer activity of  the extracts prepared from 
leaves and stems of Eryngium creticum by different 
solvents  was evaluated  by measurement of cell 
viability in MCF-7 cell line and MDA-MB-468 cells 
after treatment for 24 and 48 hours with increasing 
concentrations (5, 25, 50, 100, and 200 μg/ml) of these 
extracts. After 24 hours treatment with the aqueous 
extract from leaves and stems of Eryngium creticum 
with increasing concentrations, caused  partial 
inhibition of the proliferation of cancer cells MCF-7 
and MDA. Leaves extracts  induced a maximal  
inhibition of the cell line MCF-7 at a concentration of 
200 μg/ml. For the MDA cell line,  the maximum 
inhibition of the proliferation was  occurred at low 
concentrations (50 and 100 μg/ml).  On the other hand 
aqueous extracts from stems of Eryngium creticum did 
not exert an antiproliferative effect at all used 
concentrations.  After 24 h treatment with ethanolic 
extract, it was noted that both leaves and stems of the 
plant did not exert   antiproliferative effect of the MCF-
7 cell line at all concentrations. Leaves ethanolic extract 
at the concentration of 200 μg/ml decreased the number 
of MDA cells by 6%. Stems  extracts showed a partial 
inhibition of the proliferation at the concentrations 25 
and 100 μg/ml by 18 % and 6 % respectively. The 
methanolic extract of the  leaves at the concentration of 
200 μg/ml induced significant decrease in the number of 
MCF-7 and MDA cells by 62 % and 48 % respectively. 
While,  all concentrations of stems except 25 μg/ml 
induced antiproliferative activity by decreasing the 
number of MCF-7 cells. The most important 
concentration was 5 μg/ml which decreased the number 
of MCF-7 by 28 %.  For the MDA cells, methanolic 
extract of stems was only decreased the number of cells 
at the concentration 5 μg/ml. After 48 hours treatment 
with the three extracts from leaves and stems of 
Eryngium creticum, the number of treated cells was 
lower than the control for both MCF-7 and MDA cell 
lines. The most important decrease was noted for the 
concentration of 200 μg/ml of both leaves and stems for 
all extracts [24]. 
The  anti-proliferative and cytotoxic activities of the 
aqueous and ethanolic extracts from different parts 
(leaves, stems, roots, and the whole plant) of the fresh 
plant Eryngium creticum from the first and second 
harvest, were performed using cytotoxic   and cell 
viability (Neutral red assay on HeLa cells), and 
apoptotic activity (DNA fragmentation assay on HeLa 
cells).  The results showed that the 4 parts of this plant 
inhibited the viability of HeLa cell line in a time-
dependent (0–72 h) and dose-dependent (0–250 μM) 
manner. The ethanolic extracts from leaves of the 
second harvest were the most potent (at 48 h) with an 
IC50 value of  ≤ 47.24 μg/ml [40]. 
 
Antileishmanial activity: 
Antileishmanial activity of Eryngium creticum extract 
was tested in vitro on a culture of Leishmania donovani 
promastigotes. IC50 of  dichloromethane  extract of the  
aerial  parts of  Eryngium creticum against  Leishmania 
donovani was 38µg/ml, while  IC50 of  methanolic   
extract of the  aerial  parts of  Eryngium creticum was 
35µg/ml [47]. 
 
LD50 and toxicity: 
LD50 of Eryngium creticum aerial parts aqueous extract 
was 2400mg/kg in mice,  equivalent to 23.8g crude, and 
24.7 of the leaves extract.  However, in therapeutic 
doses, the extracts had no significant changes in the 
spontaneous motor activity and rectal temperature. They 
did not produce any other changes in behaviour, food 
and water intake and the morphology of viscera [32, 
48]. 
 
CONCLUSION:  
The current paper reviewed the chemical constituent, 
pharmacological and therapeutic effects of  Eryngium 
creticum  to be utilize in the medical practice as a result 
of its safety and effectiveness.    
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